Hasil Pencarian - Weiwei Sui

Perbaiki Hasil
  1. 1
    Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value

    Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prog... oleh Gang An, Yan Xu, Lihui Shi, Zhong Shizhen, Shuhui Deng, Zhenqing Xie, Weiwei Sui, Fenghuang Zhan, Lugui Qiu

    Diterbitkan 2014-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma

    The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma oleh Huihsou Fan, Wenqiang Yan, Lingna Li, Jingyu Xu, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chenxing Du, Shuhua Yi, Dehui Zou, Lugui Qiu, Gang An

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China

    Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China oleh Yuting Yan, Yuting Yan, Rui Lv, Rui Lv, Tingyu Wang, Tingyu Wang, Ying Yu, Ying Yu, Yanshan Huang, Yanshan Huang, Wenjie Xiong, Wenjie Xiong, Yuxi Li, Yuxi Li, Weiwei Sui, Weiwei Sui, Qi Wang, Qi Wang, Wenyang Huang, Wenyang Huang, Gang An, Gang An, Dehui Zou, Dehui Zou, Jianxiang Wang, Jianxiang Wang, Lugui Qiu, Lugui Qiu, Shuhua Yi, Shuhua Yi

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA

    P1162: FRONT-LINE RISK-ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA oleh Hesong Zou, Wei Liu, Dandan Shan, Huimin Liu, Ting Xie, Wenyang Huang, Yi Wang, Shuhua Yi, Yan Xu, Gang An, Weiwei Sui, Tingyu Wang, Lugui Qiu, Dehui Zou

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma

    Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma oleh Wenqiang Yan, Huishou Fan, Jingyu Xu, Jiahui Liu, Lingna Li, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Dehui Zou, Lugui Qiu, Gang An, Rongman Jia, Xiuyuan Hao

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities

    MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities oleh Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Huishou Fan, Lingna Li, Jian Cui, Chenxing Du, Shuhui Deng, Weiwei Sui, Dehui Zou, Yan Xu, Lugui Qiu, Gang An

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia

    Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia oleh Ying Yu, Wenjie Xiong, Tingyu Wang, Yuting Yan, Rui Lyu, Qi Wang, Wei Liu, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Jianxiang Wang, Lugui Qiu, Shuhua Yi

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia

    Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia oleh Hao Sun, Teng Fang, Tingyu Wang, Zhen Yu, Lixin Gong, Xiaojing Wei, Huijun Wang, Yi He, Lanting Liu, Yuting Yan, Weiwei Sui, Yan Xu, Shuhua Yi, Lugui Qiu, Mu Hao

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma

    Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma oleh Jian Cui, Rui Lv, Tengteng Yu, Wenqiang Yan, Jingyu Xu, Huishou Fan, Lingna Li, Yuntong Liu, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Shuhua Yi, Dehui Zou, Lugui Qiu, Gang An

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Rituximab plus cyclophosphamide and dexamethasone <i>versus</i> bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial

    Rituximab plus cyclophosphamide and dexamethasone <i>versus</i> bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a r... oleh Wenjie Xiong, Rui Lyu, Ying Yu, Tingyu Wang, Yuting Yan, Yi Wang, Wei Liu, Gang An, Shuhui Deng, Yan Xu, Weiwei Sui, Wenyang Huang, Dehui Zou, Jianxiang Wang, Lugui Qiu, Shuhua Yi

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment

    Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment oleh Xiaojing Wei, Zhen Yu, Peixia Tang, Hao Sun, Lixin Gong, Lanting Liu, Teng Fang, Yi He, Tingyu Wang, Weiwei Sui, Yan Xu, Gang An, Zhenshu Xu, Xiaoke Ma, Lugui Qiu, Mu Hao

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    The age-dependent changes in risk weights of the prognostic factors for multiple myeloma

    The age-dependent changes in risk weights of the prognostic factors for multiple myeloma oleh Chenxing Du, Lingna Li, Huishou Fan, Xuehan Mao, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chengwen Li, Jiawei Zhao, Shuhua Yi, Mu Hao, Dehui Zou, Yaozhong Zhao, Lugui Qiu, Gang An

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma

    Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma oleh Jian Cui, Tengteng Yu, Rui Lv, Jiahui Liu, Huishou Fan, Wenqiang Yan, Jingyu Xu, Chenxing Du, Shuhui Deng, Weiwei Sui, Matthew Ho, Yan Xu, Kenneth C. Anderson, Xifeng Dong, Lugui Qiu, Gang An

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients

    Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients oleh Wenjie Xiong, Tingyu Wang, Ying Yu, Yang Jiao, Jiawen Chen, Yi Wang, Chengwen Li, Rui Lyu, Qi Wang, Wei Liu, Weiwei Sui, Gang An, Dehui Zou, Lugui Qiu, Shuhua Yi, Rongman Jia, Xiuyuan Hao

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia

    Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia oleh Wenjie Xiong, Wenjie Xiong, Wenjie Xiong, Zanzan Wang, Tingyu Wang, Tingyu Wang, Tingyu Wang, Ying Yu, Ying Yu, Ying Yu, Yanshan Huang, Yanshan Huang, Yanshan Huang, Hao Sun, Hao Sun, Hao Sun, Jiawen Chen, Jiawen Chen, Jiawen Chen, Rui Lyu, Rui Lyu, Rui Lyu, Huijun Wang, Huijun Wang, Huijun Wang, Yuting Yan, Yuting Yan, Yuting Yan, Qi Wang, Qi Wang, Qi Wang, Wei Liu, Wei Liu, Wei Liu, Gang An, Gang An, Gang An, Weiwei Sui, Weiwei Sui, Weiwei Sui, Wenyang Huang, Wenyang Huang, Wenyang Huang, Dehui Zou, Dehui Zou, Dehui Zou, Zhijian Xiao, Zhijian Xiao, Zhijian Xiao, Jianxiang Wang, Jianxiang Wang, Jianxiang Wang, Guifang Ouyang, Lugui Qiu, Lugui Qiu, Lugui Qiu, Shuhua Yi, Shuhua Yi, Shuhua Yi

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy

    Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy oleh Wei Liu, Yan Xu, Yi Wang, Lugui Qiu, Ting Xie, Xiaojuan Wang, Huimin Liu, Tonghui Ma, Jianxiang Wang, Gang An, Weiwei Sui, Hesong Zou, Chunyang Wang, Chen Qiu, Dandan Shan, Wenyang Huang, Shuhua Yi, Dehui Zou

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment

    Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment oleh Lanting Liu, Zhen Yu, Hui Cheng, Xuehan Mao, Weiwei Sui, Shuhui Deng, Xiaojing Wei, Junqiang Lv, Chenxing Du, Jie Xu, Wenyang Huang, Shuang Xia, Gang An, Wen Zhou, Xiaoke Ma, Tao Cheng, Lugui Qiu, Mu Hao

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma

    LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma oleh Lixin Gong, Hao Sun, Lanting Liu, Xiyue Sun, Teng Fang, Zhen Yu, Weiwei Sui, Jingyu Xu, Tingyu Wang, Fangshuo Feng, Lei Lei, Wei Rui, Yuxuan Liu, Xueqiang Zhao, Gang An, Xin Lin, Lugui Qiu, Mu Hao

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma

    Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma oleh Ru Li, Tingyu Wang, Rui Lyv, Yi Wang, Ying Yu, Yuting Yan, Qi Sun, Wenjie Xiong, Wei Liu, Weiwei Sui, Wenyang Huang, Huijun Wang, Chengwen Li, Jun Wang, Dehui Zou, Gang An, Jianxiang Wang, Lugui Qiu, Shuhua Yi

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features

    Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features oleh Hesong Zou, Wei Liu, Yi Wang, Dandan Shan, Ting Xie, Ru Li, Huimin Liu, Wenyang Huang, Mingwei Fu, Tingyu Wang, Rui Lyu, Shuhui Deng, Weiwei Sui, Yan Xu, Shuhua Yi, Gang An, Lugui Qiu, Dehui Zou, Ting Gao, Xiuyuan Hao

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: